Abstract |
3,4-Methylenedioxymethamphetamine ( MDMA) has recently been hypothesized to be effective against the symptoms of Parkinson's disease. Therefore we tested the effects of MDMA-derivatives in the rotational behavioural model. Male Sprague Dawley rats were lesioned unilaterally with 6-hydroxydopamine at the medial forebrain bundle. MDMA was administered at doses of 2.5, 5.0 and 10.0 mg/kg, its derivatives N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butananamine ( MBDB), 3,4-Methylenedioxy-N-ethylamphetamine ( MDE) and 3,4-Methylenedioxyamphetamine (MDA) at 5.0 mg/kg respectively. All substances induced ipsilateral rotations, MDA being the most effective. MDMA induced rotations were attenuated by the selective serotonin reuptake inhibitor Citalopram but were only slightly reduced by pre-treatment with the selective serotonin synthesis inhibitor PCPA ( para-chlorophenylalanine). The effects of MDMA can therefore not fully be explained by serotonin release or by dopaminergic activity of the drugs.
|
Authors | H B Lebsanft, A Mayerhofer, K-A Kovar, W J Schmidt |
Journal | Journal of neural transmission (Vienna, Austria : 1996)
(J Neural Transm (Vienna))
Vol. 110
Issue 7
Pg. 707-18
(Jul 2003)
ISSN: 0300-9564 [Print] Austria |
PMID | 12811632
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Adrenergic Agents
- Hallucinogens
- Serotonin Antagonists
- Serotonin Uptake Inhibitors
- Citalopram
- N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine
- 3,4-Methylenedioxyamphetamine
- Oxidopamine
- N-Methyl-3,4-methylenedioxyamphetamine
- 3,4-methylenedioxyethamphetamine
- Apomorphine
- Fenclonine
- Dopamine
|
Topics |
- 3,4-Methylenedioxyamphetamine
(analogs & derivatives, pharmacology)
- Adrenergic Agents
(pharmacology)
- Animals
- Apomorphine
(pharmacology)
- Behavior, Animal
(drug effects)
- Citalopram
(pharmacology)
- Dopamine
(metabolism)
- Fenclonine
(pharmacology)
- Functional Laterality
- Hallucinogens
(pharmacology)
- Male
- Medial Forebrain Bundle
(drug effects, physiopathology)
- Models, Animal
- N-Methyl-3,4-methylenedioxyamphetamine
(pharmacology)
- Oxidopamine
(pharmacology)
- Parkinson Disease
(physiopathology)
- Rats
- Rats, Sprague-Dawley
- Rotation
- Serotonin Antagonists
(pharmacology)
- Selective Serotonin Reuptake Inhibitors
(pharmacology)
|